Advanced
search

Search results

1 – 6 of 6
View access options
Expert briefing
Publication date: 22 June 2021
Expert Briefings Powered by Oxford Analytica

Prospects for India to end-2021

Location:
PROSPECTS H2 2021

Prospects H2 2021: India
View access options
Executive summary
Publication date: 19 February 2021
Expert Briefings Powered by Oxford Analytica

BOLIVIA: Pandemic response to become more politicised
View access options
Expert briefing
Publication date: 16 March 2016
Expert Briefings Powered by Oxford Analytica

New Zealand's main political parties are divided on TPP ratification, which marks the first such division on a trade agreement in 40 years. The main opposition Labour party has…

View access options
Executive summary
Publication date: 6 January 2020
Expert Briefings Powered by Oxford Analytica

CHILE: Health reform aims to tackle key grievances

Details

DOI: 10.1108/OXAN-ES249788

ISSN: 2633-304X

Keywords

Geographic
Chile
LA/C
Topical
industry
politics
social
health
insurance
legislation
pharmaceutical
reform
prices
protest
View access options
Executive summary
Publication date: 23 October 2019
Expert Briefings Powered by Oxford Analytica

CHILE: Protests prompt Pinera reform promises

Details

DOI: 10.1108/OXAN-ES247259

ISSN: 2633-304X

Keywords

Geographic
Chile
LA/C
Topical
economy
industry
politics
emergency
legislation
pensions
protest
reform
riot
strike
wages
electricity
pharmaceutical
prices
View access options
Expert briefing
Publication date: 4 May 2017
Expert Briefings Powered by Oxford Analytica

The announcement would mark the largest subnational bankruptcy in US history, with Puerto Rico facing debt obligations of 73 billion dollars from an array of public entities and…

Access

Year

Content type

Refine By Country
{"A":[{"count":"2","title":"Australia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22Australia%22"}],"B":[{"count":"1","title":"Bolivia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22Bolivia%22"}],"C":[{"count":"2","title":"Chile","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22Chile%22"},{"count":"2","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22China%22"}],"I":[{"count":"1","title":"India","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22India%22"}],"J":[{"count":"1","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22Japan%22"}],"N":[{"count":"1","title":"New Zealand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22New+Zealand%22"}],"P":[{"count":"1","title":"Puerto Rico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22Puerto+Rico%22"}],"U":[{"count":"3","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22prices%22+AND+keyword-topical%3A%22industry%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 6 of 6
Manage cookies

We’re listening — tell us what you think

Join us on our journey